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Abstract
The signal transduction protein SmTK4 from Schistosoma mansoni belongs to the family of Syk kinases. In vertebrates, Syk
kinases are known to play specialized roles in signaling pathways in cells of the hematopoietic system. Although Syk kinases
were identified in some invertebrates, their role in this group of animals has not yet been elucidated. Since SmTK4 is the first
Syk kinase from a parasitic helminth, shown to be predominantly expressed in the testes and ovary of adult worms, we
investigated its function. To unravel signaling cascades in which SmTK4 is involved, yeast two-/three-hybrid library
screenings were performed with either the tandem SH2-domain, or with the linker region including the tyrosine kinase
domain of SmTK4. Besides the Src kinase SmTK3 we identified a new Src kinase (SmTK6) acting upstream of SmTK4 and a
MAPK-activating protein, as well as mapmodulin acting downstream. Their identities and colocalization studies pointed to a
role of SmTK4 in a signaling cascade regulating the proliferation and/or differentiation of cells in the gonads of
schistosomes. To confirm this decisive role we performed biochemical and molecular approaches to knock down SmTK4
combined with a novel protocol for confocal laser scanning microscopy for morphological analyses. Using the Syk kinase-
specific inhibitor Piceatannol or by RNAi treatment of adult schistosomes in vitro, corresponding phenotypes were detected
in the testes and ovary. In the Xenopus oocyte system it was finally confirmed that Piceatannol suppressed the activity of the
catalytic kinase domain of SmTK4. Our findings demonstrate a pivotal role of SmTK4 in gametogenesis, a new function for
Syk kinases in eukaryotes.
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Introduction
Helminth parasites of the genus Schistosoma are the causative
agents of schistosomiasis, one of the most prevalent parasitic
diseases for humans and animals worldwide [1,2]. More than 200
million people suffer from the pathological consequences of this
disease, which originate from the massive egg production of
schistosomes. The eggs cause inflammatory reactions in the gut,
bladder, spleen and liver leading to granuloma formation [1,3].
Praziquantel is the only drug applicable to all schistosome species
and is commonly used to treat patients, but treatment does not
prevent reinfection. In the light of the absence of a vaccine and the
probability of emerging resistance, a search for alternative
treatments is a commonly accepted need for further research
[4,5]. In this respect great international efforts are ongoing to
analyze the genome of this blood fluke, its transcriptome,
proteome, and glycome [6–10].
Besides their medical importance, schistosomes exhibit a
nearly unique biological phenomenon–the pairing-dependent
induction and maintenance of the sexual maturation of the
female. During a constant pairing contact, the male activates
signal transduction pathways in the female leading to the
proliferation and differentiation of cells in the reproductive
organs, such as, the ovary and vitellarium [11–14]. This is a
prerequisite for the female to produce about 300 eggs each day
[15]. One half reaches the outside of the definitive host to deliver
miracidia continuing the life cycle. The remaining eggs are
deposited in the host tissue causing pathogenesis. An egg from a
mature female consists of one fertilized oocyte, originating in the
ovary, and 30–40 surrounding vitelline cells produced in the
vitellarium. Since growth and differentiation of vitelline cells and
oocytes are probably controlled by signal transduction pathways,
efforts have been made to identify and characterize the
participating molecules.
In the last decade, several genes encoding for signaling
molecules from S. mansoni have been identified, some of which
were found to be specifically or predominantly expressed in
reproductive organs [reviewed in 16,17]. In contrast to the
vitellarium, however, less is known about signaling molecules in
the ovary. Among the molecules shown to be predominantly
expressed in this organ is SmTK4, a member of the Syk (spleen
tyrosine kinase) tyrosine-kinase family [18]. Syk kinases are
characterized by a tandem Src-homology 2 (SH2) domain and a
catalytic tyrosine kinase (TK) domain. Genome-project data have
indicated that Syk kinase genes are absent in Caenorhabditis elegans,
and in Drosophila melanogaster only the related kinase Shark (SH2
domain ankyrin repeat kinase; [19]) is present, which had
suggested a recent evolutionary origin of kinases from the Syk
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in sponge [20], and with SmTK4 also in the parasitic helminth S.
mansoni.
In mammals, Syk kinases are expressed in hematopoietic cells
playing well-characterized roles in inflammatory processes oper-
ating as downstream signaling molecules of immunoreceptors [21].
In the last years, evidence has accumulated for functions of Syk
kinases in different signal transduction pathways also in non-
hematopoietic cells [22]. Syk kinases regulate proliferation,
differentiation, morphogenesis, and survival of epithelial [23,24],
endothelial [25], and neuronal cells [26]. In the hematopoietic
system, Syk kinases interact with immune and antigen receptors
lacking intrinsic catalytic activity [27]. The tandem-like structure
of the SH2 domains confers higher binding specificity of Syk
kinases to phosphorylated tyrosine residues of upstream interac-
tion partners compared to individual SH2 domains [28].
Following receptor activation, each SH2 domain interacts with
one immunoreceptor tyrosine-based activation motif (ITAM) in
the intracellular part of the receptor leading to a conformational
change in Syk accompanied by an increase in its enzymatic activity
[29]. In SmTK4 the conserved sequence within the SH2 domains
responsible for this binding is absent, suggesting that this Syk
kinase interacts with molecules without ITAMs. Binding of
upstream partners stimulates autophosphorylation of Syk on
tyrosines within the activation loop, which influences kinase
activity or creates docking sites for SH2-containing proteins [30].
The phosphorylation of Syk can be enhanced by interacting Src
(Rous sarcoma virus kinase) tyrosine kinases [27]. In addition, a
variety of other signaling and adaptor molecules have been
reported to associate with Syk kinases, but the relevance of these
interactions have not been elucidated yet [27].
With respect to the very specialized function of Syk kinases in
the hematopoietic system of mammals, the existence of a
schistosome homolog was unexpected. SmTK4 was found to be
transcribed in the larval stages as well as adults, independently
from the pairing-status. Localization studies had demonstrated its
predominant expression in the testes of the male and ovary of the
female, but not in the vitellarium [18]. This narrow expression
profile contrasts with other identified cellular kinases in adult
schistosomes, such as the Src kinases SmTK3 and SmTK5, whose
expressions were demonstrated in all reproductive organs and
other tissues [31,32].
Recently, an interaction of the Src kinase SmTK3 with SmDia
(Diaphanous-related formin) and SmRho1 (Ras-homologous
GPTase) was shown by yeast two-hybrid (Y2H) analyses and
localization studies, indicating a role of SmTK3 in cytoskeleton
organization processes in the gonads of adult S. mansoni [33]. To
elucidate the potential function of SmTK4 in adult schistosomes,
two different strategies were followed in this study. First, by
isolating signaling molecules acting up- and downstream of
SmTK4 we expected to discover interacting proteins, whose
identity could provide evidence for functionally conserved
signaling pathways. Using a recently established S. mansoni Y2H
cDNA-library of females and males [33] and different constructs of
SmTK4 as probes, several interacting proteins were identified,
such as SmTK3 and a novel schistosome Src kinase (SmTK6), a
MAPK (mitogen-activated protein kinase)-activating protein, and
mapmodulin. Second, inhibitor and RNA interference (RNAi)
experiments were performed to functionally knock-down SmTK4
activity. With the Syk kinase-specific inhibitor Piceatannol [34,35]
or SmTK4-specific dsRNAs for RNAi, significant morphological
changes in the testes and ovary of treated schistosomes were
observed using carmine red-staining and confocal laser scanning
microscopy (CLSM). In Xenopus oocytes it was finally shown that
Piceatannol is able to suppress the catalytic activity of the TK
domain of SmTK4. Taken together, our results in S. mansoni
substantiate a pivotal role for the Syk kinase SmTK4 in
gametogenesis, a function which has not yet been shown for a
Syk kinase in other eukaryotes.
Results
Screening of a S. mansoni yeast two-hybrid library for
upstream interaction partners of SmTK4
To identify upstream binding partners of the schistosome Syk
kinase SmTK4, an adult stage Y2H cDNA-library [33] was
screened with the bait construct encoding the tandem SH2-
domain of SmTK4 as a fusion protein with the Gal4-BD (GAL4
DNA-binding domain) and the TK domain of SmTK3 (SmTK4-
SH2SH2 + SmTK3-TK pBridge; Figure 1). The schistosome TK
domain was co-expressed in a kind of yeast three-hybrid (Y3H)
approach to ensure the phosphorylation of tyrosine residues of
potential interaction partners, since yeast does not possess specific,
endogenous tyrosine-kinase activity [36]. Phosphorylation, how-
ever, is decisive for Syk-kinase interactions, because only
phosphorylated tyrosine residues of binding partners acting
upstream in a signaling hierarchy are favored binding sites for
the pocket-like structure of the tandem SH2-domain of Syk kinases
[28,37]. This principle has been successfully applied before to
investigate the interaction between SH2 domain-containing
proteins and tyrosine-containing substrates [38,39]. Without
additional protein-protein interacting domains such as SH2 or
SH3, TK domains function promiscuously [40]. Therefore, we
expected that tyrosine residues of yeast and library proteins were
phosphorylated as a consequence of the expression of an
individual TK domain. Indeed, Western-blot experiments with
anti-phosphotyrosine antibodies have shown that tyrosine phos-
phorylation of yeast proteins was enhanced when the SmTK3 TK-
domain was expressed (Phillip, unpublished). The expression of
both baits (SmTK4-SH2SH2 and SmTK3-TK) was confirmed at
the transcriptional level by RT-PCR analyses using total RNA
Author Summary
Parasitic blood flukes of the genus Schistosoma cause
schistosomiasis, one of the most important infectious
diseases for humans and animals worldwide. Besides their
medical importance, schistosomes possess unique biolog-
ical features. Among these is the sexual maturation of the
female, which requires a constant pairing contact with the
male. Pairing induces mitogenic activity and differentiation
processes in the female that lead to gonad development.
This is a prerequisite for egg production, which is closely
connected with the pathological consequences of the
disease since the eggs are trapped in different host organs,
inducing inflammatory processes. Although these correla-
tions are long known, the molecular basis of differentiation
processes in female gonads are poorly understood. In the
context of identification of signal transduction proteins
controlling female reproductive development we identi-
fied SmTK4 of S. mansoni, the first Syk-family kinase of a
parasite. By using biochemical and molecular approaches
in combination with in vitro culture and a novel
microscopical technique, we demonstrate in this study
the pivotal role of the signaling protein SmTK4 in
spermatogenesis and oogenesis of S. mansoni. This is a
new attribute for Syk kinases of eukaryotes promoting
SmTK4 as a candidate target for blocking transmission and
disease progression.
SmTK4 of S. mansoni
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of the Y2H cDNA-library resulted in the identification of 77 initial
prey clones, which underwent growth selection and b-galactosi-
dase (b-Gal) filter assays. After isolation of the prey plasmids,
sequence analyses of 14 remaining clones were performed by
BlastX to unravel their identity (Table 1). Seven clones
represented partial sequences from a schistosome homolog of a
nonsense mRNA reducing factor (NORF1) from Mus musculus
(accession number AAK08652). Three clones encoded proteins
with homology to a dipeptidyl peptidase III from Mus musculus
(accession number NP_598564). Two clones showed similarity to
the schistosome Src/Fyn kinase SmTK5 ([32]; accession number
AAF64151) and encoded a novel schistosome cellular tyrosine
kinase (CTK), named SmTK6 (accession number FN397679).
Finally, two clones were identical to the Src kinase SmTK3 from S.
mansoni, identified and characterized in a previous study ([31];
accession number CAE51198).
Qualitative and quantitative analyses of the SmTK4
upstream binding partners
To confirm their interactions and to determine their relative
binding strength in a comparative approach, yeast cells (strain
AH109) were transformed with individual prey plasmids together
with the original bait construct SmTK4-SH2SH2 + SmTK3-TK
pBridge. Additionally, yeast cells were transformed with the prey
plasmids and the bait construct SmTK4-SH2SH2 pBridge to
analyze the dependence of the observed interactions on the
additional tyrosine phosphorylation. Finally, the prey plasmids
were used for transformation together with bait constructs that
contained only one SH2 domain of SmTK4 (SmTK4-SH2(1) or
SmTK4-SH2(2) pBridge) to test if the interactions depended on
the presence of the tandem SH2-domain structure. After re-
transformation of the prey plasmids with the bait constructs
containing the tandem SH2-domain of SmTK4, with or without
the additional expression of the SmTK3 TK-domain, all yeast
clones survived growth- (Trp
2/Leu
2/Ade
2/His
2) and color
selection (b-Gal filter assays) thus confirming the observed
interactions. However, when transformation was done with the
bait plasmids containing only single SH2 domains of SmTK4, the
yeast clones containing the prey plasmids encoding the Src kinases
SmTK6 or SmTK3 were no longer able to grow. This indicated
that Src/Syk-kinase interaction depended on the presence of the
tandem SH2-domain structure. The other clones survived the
selection procedure, which is a hint for unspecific interactions
(Table S1).
To quantify the relative strengths of interaction b-Gal liquid
assays were performed. To this end yeast cells were used, which
were transformed with representative prey plasmids encoding for
each potential binding partner and the bait plasmid SmTK4-
SH2SH2 pBridge, or SmTK4-SH2SH2 + SmTK3-TK pBridge.
These experiments again confirmed the observed interactions with
SmTK4. Furthermore, the results demonstrated the strongest
interaction between the SmTK4 tandem SH2-domain and the
novel Src kinase SmTK6. This interaction was increased by a
factor of five when the SmTK3 TK-domain was present indicating
the significant influence of additional phosphorylation (Figure 2).
The interaction between the SmTK4 tandem SH2-domain and
the Src kinase SmTK3 was considerably weaker, but also
enhanced by additional phosphorylation, although to a minor
degree. The strength of interactions between the homologs of the
nonsense mRNA reducing factor (NORF1) and the dipeptidyl
peptidase III were also weak and not, or only slightly, influenced
by the state of phosphorylation (Figure 2).
SmTK6 is a Src/Abl-like kinase, which co-
immunoprecipitates and colocalizes with SmTK4
Since the novel Src kinase SmTK6 was the strongest upstream
interaction partner of SmTK4 found in this screening, we carried
out a preliminary characterization. The inserts of both SmTK6
prey clones were equal in size and about 1360 bp long.
Comparisons by multiple alignment analysis revealed homology
to CTKs and indicated that part of the 59-region of the cDNA was
Figure 1. Domain structure of SmTK4. SmTK4 contains an N-
terminal tandem SH2-domain (aa 48–143 and aa 201–292; A:
interdomain) followed by a linker region (linker) and a C-terminally
located, catalytic tyrosine kinase domain (TK, aa 881–1147). Black bars
indicate the relative position of the bait constructs SmTK4-SH2SH2
(upstream screening) and SmTK4-linker+TK (downstream screening).
doi:10.1371/journal.ppat.1000769.g001
Table 1. Identified upstream binding partners of SmTK4.
Clone group Homology (accession number) Size (bp) E-value Clone numbers
A nonsense mRNA reducing factor NORF1
[Mus musculus, AAK08652]; fl: accession number CAZ33672
3978 0.0 6, 10, 19, 28, 72, 74, 75
B dipetidyl peptidase III [Mus musculus, NP_598564];
fl: accession number CAZ29581
2034 1e
2160 16, 37, 40
C SmTK5 (Fyn/Src kinase) [Schistosoma mansoni, AAF64151];
fl: accession number AF232691
1944 3e
292 44, 45
D SmTK3 (Src kinase) [Schistosoma mansoni, CAE51198];
fl: accession number AJ585205
1944 0.0 71, 76
Clones identified by Y3H screening using the tandem SH2-domain of SmTK4 as bait (SmTK4-SH2SH2 + SmTK3-TK pBridge). From the 77 initial prey clones obtained after
library screening (mating) 14 clones resisted subsequent selection strategies, and their inserts were sequenced. BLASTX analyses showed that these clones represented
four groups (A–D); a nonsense mRNA reducing factor (NORF1, group A), a dipeptidyl peptidase III (group B), a novel Src kinase (SmTK6) with similarity to the Src/Fyn
kinase SmTK5 (group C), and the already known schistosome Src kinase SmTK3 (group D). To depict the e-values of the candidate clones, of which only partial
sequences were obtained from the Y2H library, the full-length cDNA sequences (fl) of the clones were identified in the genome data set of the S. mansoni sequencing
project ([6]; www.sanger.ac.uk, www.genedb.org), or in the NCBI database (www.ncbi.nlm.nih.gov) and used for BlastX analyses. The sizes of the full-length sequences,
the appropriate e-values, and the yeast clone numbers are given.
doi:10.1371/journal.ppat.1000769.t001
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sequencing data (www.sanger.ac.uk), the whole coding sequence
was identified in silico. To verify its existence in our S. mansoni
strain, we performed RT-PCR analyses using the primer pair
TK6-fl-59 (59-CTCATTATGGGAATTTGTTTGTG-39 con-
taining the ATG codon) and TK6-fl-39 (59-AATTATCTAAA-
TATTGAGCTTCTG-39 containing the TAA stop codon), and
total RNA from mixed-sex worms. Amplification products of the
expected size were obtained and cloned. Sequence analysis showed
that the complete cDNA sequence of SmTK6 is 1698 bp long
encoding a protein of 566 amino acids (accession number
FN397679). In silico analyses indicated the presence of one SH2,
one SH3, and a TK domain that characterize CTKs of the Src
family. Preliminary phylogenetic analyses showed that SmTK6
has also some similarity to the class of Abl kinases indicating that
this kinase is a kind of Src/Abl intermediate (Beckmann,
unpublished).
To additionally confirm the binding capacity of SmTK6 and
SmTK4, co-immunoprecipitation (co-IP) experiments were per-
formed. To this end the tandem SH2-domain of SmTK4 was
cloned as a FLAG-tagged construct into one multiple cloning site
of the pESC-His yeast expression vector. In the second multiple
cloning site of the same vector a nearly complete version of
SmTK6 was cloned as a cMyc-tagged fusion. Following yeast
transformation and subsequent growth selection, protein expres-
sion was induced by galactose. The expression of the recombinant
proteins was proven by Western-blot analyses (results not shown).
Following co-IP, the presence of the FLAG- and cMyc-tagged
schistosome proteins was finally confirmed by Western-blot
analyses (Figure 3). Bands of the predicted sizes of 31 kDa
(SmTK4-SH2SH2) and 55 kDa (SmTK6) were detected only in
lysates precipitated by each of the antibodies, not in a control
precipitated without antibody (Figure 3B). This result confirmed
that the tandem SH2-domain of SmTK4 is able to bind to
SmTK6 independent of additional yeast Gal4-AD/BD (GAL4
activating domain/DNA-binding domain) fusion protein partners.
By in situ hybridization, finally, SmTK6 was localized in the
parenchyma of both genders, in the testes of the male and the
ovary of the female (Figure 4, A–C). From the staining pattern
obtained we cannot exclude that SmTK6 is also transcribed in the
Figure 2. Comparative b-Gal liquid assays to determine the relative binding strengths of SmTK4 upstream interaction partners. For
this analysis, yeast cells (strain AH109) were re-transformed with one representative prey clone of each group together with the bait SmTK4-SH2SH2
pBridge (light grey) or SmTK4-SH2SH2 + SmTK3-TK pBridge (dark grey). The tested clones were (from left to right): SmTK6 (Src kinase), SmTK3 (Src
kinase), a homolog of a dipeptidyl peptidase III, and a homolog of a nonsense mRNA reducing factor (NORF1). As control, untransformed yeast cells
were used (control). The statistical evaluation of three independent measurements of b-Gal activity (n=3) is shown (error bars are indicated).
Student’s t-test (two-tailed):
*p,0.002.
doi:10.1371/journal.ppat.1000769.g002
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pattern corresponded to that of SmTK4 [18], additionally
supporting the conclusion that these kinases interact.
Screening of a S. mansoni yeast two-hybrid library for
downstream interaction partners of SmTK4
Downstream binding partners of Syk kinases are known to
interact with the linker region or with the TK domain of a Syk
kinase [41]. Furthermore, binding can be influenced by tyrosine
residues within the TK domain, which are phosphorylated in trans
by, e.g., Src kinases [27]. For these reasons we used SmTK4-
linker+TK + SmTK3-TK pBridge as the bait construct for library
screening to identify binding partners acting downstream of
SmTK4 (Figure 1). This bait construct expressed the complete
linker region together with the TK domain of SmTK4 fused to the
Gal4-BD (multiple cloning site I, MCS I) as well as the TK domain
of SmTK3 (multiple cloning site II, MCS II) to ensure tyrosine
phosphorylations of bait proteins (Y3H).
The expression of the bait constructs SmTK4-linker+TK (+
SmTK3-TK) pBridge, SmTK4-linker pBridge, and SmTK4-TK
pBridge was confirmed by RT-PCR analyses using total RNA
extracts of the transformed yeast cells and appropriate primers
(results not shown). The mating with the S. mansoni Y2H library
resulted, after subsequent growth selection and b-Gal filter assays,
in 19 clones as potential candidates for interaction. The
appropriate prey plasmids were isolated and their inserts
sequenced. By BlastX analyses the identities of these potential
binding partners were unraveled due to their homology to proteins
in the NCBI-database (Table 2). Three clones showed homology
to small heat-shock proteins (HSPs) from Caenorhabditis elegans
(accession number NP_001024376). One clone encoded a related
but not identical protein, which was also homologs to small HSPs
(accession number NP_001024376), as well as to the major egg
antigen Smp40 from S. mansoni (accession number P12812). Two
prey clones encoded a protein with homology to caspase 3 from
Homo sapiens (accession number AAP36827). The inserts of five
further clones encoded homologs of the MAPK-activating proteins
PM20/PM21 from different organisms, such as Homo sapiens
(accession number NP_001108072). One clone represented a
leucine-rich protein from S. mansoni (accession number Q86QS6),
which exhibited homology to mapmodulin from Drosophila
melanogaster (accession number NP_001097361). Seven clones
showed the same insert sequence encoding a protein with no
significant homology to any known proteins from other organisms.
Qualitative and quantitative analyses of the SmTK4
downstream binding partners
b-Gal liquid assays were performed to quantify the relative
binding strengths of SmTK4 and its identified downstream
interaction partners. To this end yeast cells were transformed
with representative prey plasmids of the groups A–D together with
the original bait construct SmTK4-linker+TK + SmTK3-TK
pBridge to confirm the interactions and, additionally, with
SmTK4-linker+TK pBridge to analyze the dependency of
interactions on the supplementary tyrosine phosphorylation.
Furthermore, to determine whether the linker region and/or
TK domain of SmTK4 were responsible for binding, yeast cells
were transformed with individual prey plasmids and further bait
constructs containing only the linker region (SmTK4-linker
pBridge) or only the TK domain of SmTK4 (SmTK4-TK
pBridge). The performed assays again confirmed the observed
interactions with SmTK4 and, additionally, demonstrated signif-
icant differences in the relative binding strengths. The interactions
between the small HSP and caspase 3 homologs with the different
fragments of SmTK4 were very weak. With respect to the different
SmTK4 fragments, the small HSP showed the strongest binding to
the isolated linker region of SmTK4, whereas the caspase 3
homolog showed no significant differences in the relative binding
strengths (Figure 5). However, the interactions of the MAPK-
activating protein (PM20/PM21) and the mapmodulin with
SmTK4 were stronger and differed between the SmTK4
fragments (Figure 5). In the case of the MAPK-activating protein,
the interaction with the combined linker region and TK domain of
SmTK4 was slightly enhanced by additional phosphorylation.
However, with the isolated linker region, the interaction was
nearly seven times stronger. In contrast, the interaction with the
TK domain was very weak (Figure 5). These results showed that
the MAPK-activating protein bound presumably to the linker
region of SmTK4, and that this binding was negatively influenced
by the presence of the TK domain. Furthermore, binding to the
linker region was strong even without additional phosphorylation.
The interaction between mapmodulin and the combined linker
and TK domain of SmTK4 was also slightly enhanced by the
additional phosphorylation, as in the case with the MAPK-
Figure 3. Co-immunoprecipitation of SmTK4 and SmTK6. The tandem SH2-domain of SmTK4 was expressed with a FLAG-tag, and the
sequence of SmTK6 with a cMyc-tag in yeast. Co-IPs were done with lysates from yeast (strain YPH501) expressing both proteins using anti-FLAG- (F)
or anti-cMyc antibodies (M). After co-IP, the proteins were separated on a SDS-PAGE and blotted onto a nitrocellulose membrane. A: INDIA-Ink
staining of the nitrocellulose membrane (N: negative control without antibody, L: yeast lysate before immunoprecipitation). B: Detection of SmTK6
full-length-cMyc (55 kDa) and SmTK4-SH2SH2-FLAG (31 kDa) by Western blots using anti-cMyc or anti-FLAG-tag antibodies, respectively.
doi:10.1371/journal.ppat.1000769.g003
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Representative sections (5 mm) of adult schistosome couples (males and females are indicated), which were hybridized with DIG-labeled
antisense-RNA probes of SmTK6 (A–C), MAPK-activating protein (D–F), or mapmodulin (G–I). For control, a DIG-labeled sense-RNA probe of
mapmodulin was used (J–L). mRNA transcripts of all genes were detected in the ovary (o), the testes (t), and the parenchyma (p). No MAPK-
activating protein gene-transcripts or mapmodulin transcripts were found in the vitellarium (v), but weak SmTK6 signals were observed in this
organ. In the muscles (m), the subtegument (s), or the gastrodermis (ga), no signals were detected .[ g ,g u t ;g y ,g y n a e c o p h o r i cc a n a l ;s c a l eb a r :
50 mm.]
doi:10.1371/journal.ppat.1000769.g004
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domain, mapmodulin bound strongly to both with a slight bias
towards the TK domain (Figure 5). Again, interaction was strong
even without additional phosphorylation. As in the case with the
MAPK-activating protein, the interactions of mapmodulin with
the linker region or the TK domain were negatively influenced by
the presence of both domains, indicating a potential inhibitory
intramolecular conformation of these domains when expressed as
a fusion protein.
For the two strongest downstream binding partners of SmTK4,
MAPK-activating protein and mapmodulin, colocalization with
SmTK4 in the ovary of the female and testes of the male was
shown by in situ hybridizations (Figure 4, D–I) supporting the
conclusion for interaction. Corresponding to the SmTK4
transcriptional profile [18], both binding partners were found to
be transcribed also in parenchyma of both genders, but not in the
vitellarium of the female.
Piceatannol treatment of adult S. mansoni
Recently, we introduced an experimental approach to investi-
gate the role of schistosome CTKs by specific inhibitors. Using the
Src kinase-specific inhibitor Herbimycin A for treatment of
schistosome couples in vitro, we demonstrated that mitogenic
activity and egg production were significantly reduced in females
[42]. This was correlated with the reduced stability of the Src
kinase SmTK3 from S. mansoni. Here we have combined the
inhibitor approach with a novel way of phenotypic analysis at the
morphological level. Based on the procedure established by
Machado-Silva et al. [43] and Neves et al. [44], we investigated
inhibitor effects by treatment of schistosome couples in vitro with
subsequent fixation and carmine red-staining. By CLSM finally,
we looked for morphological effects with a focus on the testes of the
male and the ovary of the female, because SmTK4 expression has
been detected mainly in these organs [18]. To investigate whether
the inhibitors influence egg production of paired females, the
numbers of eggs were counted daily during the treatment period.
Towards this end schistosome couples were treated in vitro with
the Syk kinase-specific inhibitor Piceatannol (3,4,39,59-tetrahy-
droxy-trans-stilbene). This phenolic stilbenoid inhibits the activity
of Syk kinases in cell culture with an IC50 value of 10 mM for the
human Syk kinase [45]. For tissues it is used at higher
concentrations of 100–200 mM [34].
For S. mansoni couples maintained in vitro, we used Piceatannol at
concentrations of 35 mM, 70 mM, and 100 mM over a period of six
days to investigate dosage- and time-dependent effects. The
medium was changed daily along with the inhibitor, and the
viability of the worms as well as their pairing stability was examined.
During this time period, no alterations in behavior, mortality rates,
or worm pairing compared with DMSO (dimethyl sulfoxide)-
treated controls could be observed (results not shown). Each day, an
aliquot of treated worm couples was fixed in AFA, stained with
carmine red and analyzed by CLSM. The control males and
females, treated for the same time with DMSO, showed no
morphological changes in the testes or ovaries (Figure 6, A–B)
compared to completely untreated schistosomes ([43,44], results not
shown).Thetestes ofuntreated orDMSO-treated adultschistosome
males are composed of several testicular lobes containing numerous
spermatogonia and spermatocytes in different stages of maturation.
Maturation of spermatocytes (spermatogenesis) begins in the dorsal
part of the lobes with big round spermatogonia and ends in the
ventral part with smaller elongated mature sperms (spermatozoa,
Figure 6A). In the ventral part of the testicular lobes and in the vas
deferens elongated mature sperms can be detected as well as in the
anterior sperm vesicle, which is full of sperms (Figure 6A, arrows
and asterisk). During treatment with 70 mM Piceatannol, however,
this morphology changed considerably. After two days the size of
the lobes was already slightly reduced, and the number of
spermatocytes diminished (results not shown). After six days these
effects were even more dramatic. The testicular lobes were shrunk
accompanied by a significant decrease in the number of
spermatocytes per lobe (Figure 6C). In the ventral part of the
testicular lobes and in the anterior sperm vesicle, no elongated
mature sperms were detected in most of the males (Figure 6C,
asterisk). Instead of mature sperms, the sperm vesicle contained, in
several cases, undifferentiated round spermatocytes. In addition to
the effects within the testes, the inhibitor also caused morphological
changes in the ovary. In untreated or DMSO-treated mature
females the ovary is composed of small oogonia and immature
Table 2. Identified downstream binding partners of SmTK4.
Clone group Homology (accession number) Size (bp) E-value Clone numbers
A small heat-shock protein (hsp 25)
[Caenorhabditis elegans, NP_001024376]; fl: accession number CAZ30399
1239 5e
206 1, 29, 57
Smp40 [Schistosoma mansoni, P12812]; fl: accession number CAZ32467;
small heat-shock protein (hsp 25) [Caenorhabditis elegans, NP_001024376]
1404 2e
257;3 e
208 14
B caspase 3 [Homo sapiens, AAP36827]; fl: accession number CAZ30529 891 4e
249 4, 7
C putative MAPK-activating protein PM20/PM21
[Homo sapiens, NP_001108072]; fl: accession number CAZ36990
792 7e
26 9, 12, 13, 26, 27
D leucine-rich nuclear phosphoprotein 32-related
[Schistosoma mansoni, Q86QS6]; fl: accession number CAZ28784;
mapmodulin [Drosophila melanogaster, NP_001097361]
660 1e
2116;9 e
236 36
E no significant homology 8, 22, 23, 24, 28, 35, 37
Clones identified by Y3H library screening using the linker region combined with the TK-domain of SmTK4 as bait and separately the TK domain of SmTK3 (SmTK4-
linker+TK + SmTK3-TK pBridge). From the 72 initial prey clones obtained following library screening (mating) 19 clones remained positive after further selection
procedures. From these clones the preys were isolated, their inserts sequenced, and after BLASTX analyses arranged into five groups (A–E) due to their homologies. The
last group contains the clones showing no significant homology in the BLAST analyses (group E). The other four groups represent proteins with homologyt os m a l lH S P s
as well as to the schistosome major egg antigen Smp40 (group A), a caspase 3 (group B), a MAPK-activating protein (group C), and a leucine-rich protein with homology
to mapmodulin (group D). To depict the e-values of the candidate clones, of which only partial sequences were obtained from the Y2H library, the full-length cDNA
sequences (fl) of the clones from group A–D were identified in the genome data set of the S. mansoni sequencing project ([6]; www.sanger.ac.uk, www. genedb.org), or in
the NCBI database (www.ncbi.nlm.nih.gov) and used for BlastX analyses. The sizes of the full-length sequences, the appropriate e-values, and the clone numbers are given.
doi:10.1371/journal.ppat.1000769.t002
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posterior part ([46], Figure 6B). After treatment with 70 mM
Piceatannol for six days, in most of the females the number of large
primary oocytes was clearly increased compared to the small,
immature oocytes. Furthermore, the high number of large oocytes
was distributed all over the ovary and no longer concentrated to the
posterior part (Figure 6D). Using the lower concentration of 35 mM
Piceatannol for worm treatment led to similar morphological
changesinthe testesandovary,althoughwitha delayof1–2days. A
higher concentration (100 mM) led to the same phenotypes, but in a
shorter time period indicating a time- and dosage-depending effect
of this inhibitor on schistosomes (results not shown). Although at a
comparatively low level, SmTK4 is also transcribed in subtegu-
mental and parenchyma tissues in adults [18]. However, in these
tissues we did not see an effect, which may be due to their low
mitogenic activity compared to the gonads.
To analyze the influence of Piceatannol on the egg production
of paired females, the number of eggs was determined for treated
couples maintained in vitro.7 0 mM Piceatannol reduced the
number of eggs per couple within 7 days to 51% compared to
the DMSO control (Figure 7).
Since obvious morphological changes after Piceatannol treat-
ment were observed, the question arose, whether these effects
could be ascribed to the inhibitor’s effect on SmTK4. To answer
this question, evidential and experimental data were assembled
pinpointing SmTK4 as the target of Piceatannol. First, Southern-
blot analysis had shown that SmTK4 is a single copy gene [18],
and searches through the schistosome genome data ([6], assembly
version 3.1; www.sanger.uk) provided no evidence for the
existence of other kinases of the Syk class. Therefore, we assume
that SmTK4 is the only Syk kinase present in S. mansoni. Since at
the concentrations used Piceatannol is specific for Syk kinases
Figure 5. Comparative b-Gal liquid assays to determine the relative binding strengths of SmTK4 downstream interaction partners.
Yeast cells (strain AH109) were re-transformed with one representative prey clone of the groups A–D together with the bait SmTK4-linker+TK +
SmTK3-TK pBridge (white), SmTK4-linker+TK pBridge (light grey), SmTK4-linker pBridge (dark grey), or SmTK4-TK pBridge (black). The tested clones
were (from left to right): a homolog of a small HSP 25, a caspase 3 homolog, a putative MAPK-activating protein (PM20/PM21), and a mapmodulin
homolog. The statistical evaluation of six independent measurements of b-Gal activity (n=6) is shown (error bars are indicated). Student’s t-test (two-
tailed):
*p,0.0001,
**p,0.005,
*** p,0.05.
doi:10.1371/journal.ppat.1000769.g005
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in S. mansoni. Furthermore, localization studies had indicated the
testes and ovary as the only reproductive organs transcribing
SmTK4, which is not transcribed in the vitellarium. In this organ,
no morphological changes following inhibitor treatment were
observed (result not shown).
RNAi experiments to knock down SmTK4
To specifically attribute the effect of Piceatannol to SmTK4, we
post-transcriptionally inhibited SmTK4 using dsRNAs (RNAi). To
this end, SmTK4-specific dsRNAs were generated spanning both
SH2 domains, including the interdomain A (linker region between
the SH2 domains, Figure 1; 813 bp long). To exclude nonspecific
side-effects on other tyrosine kinases, SmTK3-specific dsRNAs
were also generated and applied as control. Based on the protocol
from Ndegwa et al. [47], ten S. mansoni couples were electropo-
rated with a single square-wave impulse and 25 mg of SmTK4- or
SmTK3-specific dsRNAs, respectively. As an additional control,
worm couples were electroporated under the same conditions, but
without dsRNA.
Figure 6. Morphology of the testes and ovary of Piceatannol- or dsRNA-treated S. mansoni. Confocal scanning laser microscope images of
carmine red-stained whole-mount preparations of S. mansoni couples (A, C, E, G: males; B, D, F, H: females) treated with Piceatannol (C, D) or dsRNA
(G, H). A, B: control worms treated with DMSO only; C, D: worms treated for 6 days with 70 mM Piceatannol; E, F: control worms after electroporation
without dsRNA; G, H: worms after electroporation with SmTK4 dsRNA. [e: egg, io: immature oocytes, mo: mature oocytes, od: oviduct, vd: vitelloduct;
asterisk: sperm vesicle, arrows: mature sperms; scale bar: 40 mm]
doi:10.1371/journal.ppat.1000769.g006
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analyzed SmTK4 transcript levels in the three independent groups
of electroporated worms by semi-quantitative RT-PCR (Figure
S1). As endogenous standard, the housekeeping gene SmPDI
(protein disulfide isomerase; [48]) was used. Five days after
electroporation, total RNA was extracted from one half of the
worm couples and the SmTK4 transcript level determined by RT-
PCR analysis. The products were analyzed by agarose gel
electrophoresis, and the intensities of the amplification products
were densitometrically quantified using RT-PCR results of SmPDI
for normalization. In three independent experiments, the SmTK4-
mRNA levels were significantly reduced, although at different
levels. In worms electroporated with SmTK4-dsRNA, transcript
levels decreased to 10–32% compared to control worms, which
had been electroporated without dsRNA. Worm couples treated
with SmTK3-specific dsRNAs showed no alterations in the
SmTK4-transcript level, indicating the specific silencing effect of
the SmTK4-dsRNAs (Figure S1).
Finally, by carmine red-staining and CLSM the morphology
of those dsRNA-treated worms was investigated, which revealed
the strongest silencing effect (transcript reduction to 10%)
according to RT-PCR analysis. Control worms, electroporated
without dsRNA, showed no alterations in the morphology of the
testes or ovary (Figure 6E–F). Additional control worms
electroporated with SmTK3-specific dsRNA also showed no
morphological alterations in these tissues (results not shown).
However, many of the SmTK4-dsRNA electroporated worm
couples exhibited phenotypes that were qualitatively compara-
ble to the phenotypes observed after Piceatannol treatment
(Figure 6G–H). In males, the size of the testicular lobes and the
number of spermatocytes were reduced, and nearly no mature
elongated sperms were detected in the ventral part of the lobes
or within the sperm vesicle, but some immature spermatogonia
(Figure 6G, asterisk). In the ovary of the female, the number of
mature oocytes was increased, but not to the same extent as
observed after Piceatannol treatment (Figure 6H).
GVBD-assay in Xenopus oocytes to study SmTK4 activity
under the influence of Piceatannol
To finally test, whether SmTK4 exerts signal transduction
activities which can be suppressed by Piceatannol, we made use of
the Xenopus oocyte system [49]. Previous studies had shown that
signal transduction proteins of schistosomes can be efficiently
expressed in Xenopus oocytes. Moreover, parasite kinase activities
were already studied in this heterologous system owing to their
capacity to induce resumption of meiosis or germinal vesicle
breakdown (GVBD) [50,51]. To analyze the GVBD-inducing
capacity of SmTK4 and inhibitor effects on this kinase, two
constructs were cloned as templates for cRNA synthesis, a full-
length construct and a shortened version of SmTK4 containing
only the catalytic TK domain. Following cRNA injection, GVBD
was studied by the appearance of a white spot at the center of the
animal pole of the oocyte. The results showed that in the absence
of progesterone, a steroid inducer of GVBD [49] used for positive
control, the TK domain of SmTK4 was able to induce 100%
GVBD. This confirmed its catalytic activity (Table S2). In non-
injected oocytes, no GVBD was observed under the same
conditions as well as in oocytes transfected with the full-length
variant of SmTK4. This was probably due to a close conformation
of the TK domain within the complete protein. When oocytes
containing the catalytic TK domain of SmTK4 were incubated
with increasing concentrations of Piceatannol, however, GVBD
was negatively influenced in a concentration-dependent manner
and completely suppressed at a concentration of 5 mM already.
The inhibitor had no effect on non-injected oocytes, and did not
inhibit progesterone-dependent maturation even when it was used
at the concentration of 100 mM (Table S2). These results
confirmed the specific action of Piceatannol on SmTK4.
Discussion
SmTK4 was the first Syk kinase identified in a parasitic
helminth and shown to be predominantly expressed in the testes
and ovary of adults [18]. To elucidate signaling cascades in which
SmTK4 participates, screenings of a S. mansoni adult stage Y2H
library were performed. Using the tandem SH2-domain as bait,
upstream binding partners of SmTK4 were identified such as
homologs of a nonsense mRNA reducing factor, a dipeptidyl
peptidase III, SmTK3, and SmTK6. Although most clones
represented homologs of a nonsense mRNA-reducing protein
factor (group A, [52]), binding tests with individual SH2 domains
failed, indicating nonspecific interaction. Furthermore, interac-
tions between Syk kinases and such factors are not known. Both
arguments also apply to dipeptidyl peptidase III (group B, [53]),
which represents another nonspecific interaction partner. The
other two upstream interaction partners belong to the Src family of
CTKs (groups C, D). One represented the already characterized
SmTK3 [31], whilst the other was a novel Src kinase named
SmTK6. In contrast to group A and B clones, the binding of both
Src kinases occurred only with the tandem SH2-domain of
SmTK4, and was enhanced by additional phosphorylation in
yeast, in the case of SmTK6 by a factor of five. This confirmed the
specificity of the detected Syk-Src interactions.
SmTK6 turned out to be the strongest upstream interaction
partner, and in situ hybridizations demonstrated its transcription
Figure 7. Influence of Piceatannol-treatment on egg produc-
tion of S. mansoni couples. For this, 20 worm couples each were
cultured for 7 days in the absence (DMSO control) or presence of 70 mM
Piceatannol, and the egg numbers were determined at a daily basis. The
statistical evaluation of four independent experiments (n=4) is shown
(error bars indicated). Student’s t-test (two-tailed):
*p,0.01.
doi:10.1371/journal.ppat.1000769.g007
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corresponds to the transcription profiles of SmTK4, but also
SmTK3, which among other tissues is also expressed in the testes
and ovary [31]. In addition to the interaction analyses, the
colocalization of SmTK6, SmTK3 and SmTK4 allows the
conclusion that these kinases cooperate in the gonads. Src-Syk
interactions are already known from other systems. In mammalian
immune cells, Src kinases recruit downstream-acting Syk kinases
to the plasma membrane to activate them by phosphorylation
[54,55]. Thus, high-affinity binding sites are created for molecules
acting downstream of Syk [27] that bind to phosphotyrosine
residues within the linker region, or the TK domain of Syk
[27,41,56]. From these data we hypothesize that SmTK3 may
recruit SmTK6 to the plasma membrane, where the latter one
becomes phosphorylated. This may be a prerequisite for binding
of SmTK4 by its SH2 domain. By co-IP we found further evidence
for SmTK4-SmTK6 binding, which supports the sketched
scenario. Future studies will aim to analyze these interactions in
more detail.
As downstream interaction partners of SmTK4 homologs of
caspase 3, small HSP, a PM20/PM21 type MAPK-activating
protein, mapmodulin, and a protein with non-significant similarity
were found. The caspase 3 homolog (group B, [57]) showed the
weakest relative binding strength with all SmTK4 subfragments.
Although for ZAP-70, the second member of the Syk-kinase family
in mammals, an influence on caspase pathways has been described
[58], this influence is indirect [59], and no direct interaction
between Syk kinases and caspases has been described yet. In light
of these facts, a nonspecific binding may have occurred. The
relative binding strength of the small HSP homolog (group A) was
slightly stronger as for caspase 3. Besides other functions [60],
HSPs fulfill chaperone functions, and a protective role of HSP90
for ZAP-70 has been demonstrated [61]. Therefore, we assume
that the schistosome HSP homolog may fulfill a chaperone-like
function for SmTK4. Mapmodulin (group D), a microtubule-
associated protein [62,63], showed high relative binding strengths
to both the linker region and the TK domain indicating that it is
able to bind to both fragments of SmTK4. This suggests that
SmTK4 may influence the reorganization of the cytoskeleton in
spermatocytes or oocytes, which is supported by the in situ-
hybridization data showing mapmodulin transcripts in the testes
and ovary. Indeed, Syk kinases are known to phosphorylate
substrates involved in cytoskeleton organization, or components of
the cytoskeleton such as microtubules directly [23,64,65]. Finally,
the MAPK-activating protein of the PM20/PM21 type (group C)
showed the strongest relative binding activity to SmTK4. Since
this group of proteins lacks defined structural or functional
domains, the molecular basis for interaction as well as the function
of the schistosome MAPK-activating protein remains uncertain
[66,67]. Results of our study provide first evidence for its binding
to the linker region of SmTK4. MAPK signaling is acknowledged
to be initiated by upstream molecules, such as growth factors and
RTKs, which are known to be components of signaling cascades
controlling proliferation, differentiation, and survival of cells. A
critical role of Syk for MAPK activation has been postulated [68],
although no direct interactions between Syk kinases and a MAPK-
activating protein were shown yet. In situ-hybridization experi-
ments colocalized transcripts of the schistosome MAPK-activating
protein in the testes and ovary providing further evidence for
interaction. This allows the speculation that SmTK4 may trigger a
MAPK signaling-pathway in the gonads probably influencing cell
proliferation. We tried to find evidence for MAPK activation using
Western-blot analyses with antibodies directed against phosphor-
ylated or non-phosphorylated forms of human MAP kinases and
protein homogenates from mixed sex schistosomes. In another
independent study, these antibodies showed a high specificity also
for Echinococcus MAP kinases [69]. Although a highly conserved
MAPK homolog exists in the genome of S. mansoni ([6], accession
number XP_002575049), its structure may be different since the
antibodies were not able to detect a band of the expected size
(results not shown). However, the capacity of the TK domain of
SmTK4 to induce GVBD in Xenopus oocytes provided at least
indirect evidence for the potential of the schistosome Syk kinase to
activate a MAP kinase cascade since GVBD is only induced when
this signaling pathway has been activated [70].
The differentiation of germ cells in vertebrates and invertebrates
depends on the re-organization of the actin and tubulin
cytoskeletons [71–73]. The participation of Syk kinases in these
processes, either directly by phosphorylation of cytoskeleton
components [64], or indirectly by the activation of further
signaling molecules has already been described [74,75]. The
identity of the isolated up- and downstream interaction partners of
SmTK4 allowed first speculations for a role of SmTK4 in signaling
pathways, regulating the proliferation and/or differentiation of
germinal cells by activation of a MAPK pathway and/or by
influencing cytoskeleton rearrangements. To investigate a cyto-
skeletal role, the Syk kinase-specific inhibitor Piceatannol was used
for functional inhibition of the protein and second, SmTK4-
specific dsRNAs were applied for post-transcriptional gene
silencing. Since Southern-blot [18] and in silico analyses confirmed
that SmTK4 is the only Syk kinase in S. mansoni, and since at the
concentrations used Piceatannol only inhibits Syk kinases [34,45],
the morphological effects observed by CLSM could be specifically
attributed to an inhibition of SmTK4. This conclusion was
supported by GVBD assays in Xenopus oocytes confirming that
Piceatannol is able to specifically inhibit the catalytic activity of the
TK domain of SmTK4 in a concentration-dependent manner.
Inhibitor and dsRNA treatment seemed to disrupt sperm
development in schistosome males at an early stage, since the
number of mature sperms as well as of spermatocytes was reduced
within the testicular lobes. It seems likely that the inhibition
influenced the proliferation of the spermatogonial cells in the
dorsal part of the testes. The proliferation of these cells is necessary
for the initiation of spermatogenesis and the continuous produc-
tion of mature sperms [76]. Thus, a dysfunction of spermatogen-
esis at this early stage would lead to the absence of mature sperms.
This coincides with studies from other organisms (mouse, human)
showing that the proliferation of spermatogonial cells is activated
by CTKs. Accordingly, Src-specific inhibitors or RNAi led to
dysfunctions in spermatogenesis [76]. For CTKs of the Src family,
an involvement in spermatogenesis is well-known, and this has also
been hypothesized for the Lyn- and Fyn-family kinases [76,77].
Indeed, the CLSM analysis of S. mansoni couples treated with the
Src kinase-specific inhibitor Herbimycin A also showed signifi-
cantly reduced numbers of sperms in the ventral part of the
testicular lobes and within the sperm vesicle [78]. It was shown
before that Herbimycin A affects the biochemical activity of
SmTK3 [31], but we cannot exclude that it also affects SmTK6
activity. In contrast to the Src-family kinases, however, the
involvement of a Syk kinase in spermatogenesis has not been
confirmed previously in eukaryotes.
Harayama etal.[79] firstreported the existenceofa Sykkinasein
spermatozoa of mammals. Here Syk is phosphorylated and
activated by a cAMP-activated PKA indicating the involvement
of a signaling pathway, which differs from that in hematopoietic
cells. It was speculated that the PKA-Syk pathway is associated with
the fertilization capacity of sperms [79], but functional data have
not been provided yet. In untreated schistosome females the
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oogonia which have stem-cell character, whereas the posterior part
contains mature primary oocytes with enlarged cytoplasms. As in
other trematodes, primary oocytes leave the ovary to become
fertilized within the oviduct before entering meiosis [46,80]. Upon
Piceatannoltreatment, anincreasednumberofprimary oocytesand
fewer immature oocytes were observed in females. One explanation
for this structural change is an inhibition of processes occurring
early in oocyte development such as oogonial divisions, leading to a
reduced supply of primary oocytes. This is similar to the phenotype
observed in the testes and supported by the result of the egg-count
reduction test, which showed a significant reduction of egg
production within one week in paired females treated with
Piceatannol. We expected a complete fading of egg production
with elongated time of treatment. However, a long-term effect of
Piceatannol on egg production could not be studied because worms
died nearly 10 days after treatment in culture before egg production
had terminated. Furthermore, a hatching assay showed no
morphological differences between developing eggs of inhibitor-
treated worms or controls, indicating that SmTK4 may not have an
essential function for egg maturation or developing miracidia
(results not shown). RNAi approaches performed to post-transcrip-
tionally silence SmTK4 resulted in similar phenotypes in the testes
and ovary of adult S. mansoni. This indicates that electroporation
combined with soaking was suitable and efficient to induce RNA
silencing in the gonads. In previous studies, RNAi effects were
observed for genes expressed in the tegument or in the gastrodermis
[47,81], tissues more easily accessible to dsRNA. At this time-point,
the RNAi protocolfor adult schistosomes is not fully reproducible in
our hands, as indicated by variable rates of SmTK4 knock-down in
the three independent experiments, and by the absence of a
phenotype in the SmTK3-dsRNA control. Since the SmTK4-
dsRNAs reduced the transcript levels incompletely, phenotypes had
been obtained that were qualitatively but not quantitatively
comparable to the Piceatannol-induced phenotypes. The efficiency
of this inhibitor to suppress SmTK4 function was higher resulting in
more dramatic phenotypes in the gonads of adult schistosomes.
In oocytes of marine nemertean worms (Cerebratulus sp.),
inhibitor studies also showed evidence for a role of Syk kinases,
as well as of Src-like CTKs during oocyte maturation [82]. Using
the nonspecific tyrosine kinase inhibitor genestein (50–100 mM), or
the Syk-kinase specific inhibitor Piceatannol (50–100 mM) a
decrease in the maturation of oocytes was observed, indicated by
reduced GVBD occurring in early meiosis, and also by reduced
MAPK activity. With Src-kinase inhibitors (100 mM PP2, 20 mM
SU6656) no reduction in GVBD was observed, but in that of
MAPK activity. Based on their data Stricker & Smythe [82]
propose that in oocytes of nemertean worms the signal is
transduced from RTKs to Syk kinases, followed by Src kinases
and ending in a MAPK-signaling pathway that leads to the
activation of MPF (maturation-promoting factor) and GVBD.
This model is basically, but not completely supported by the
findings of our study. Besides the indirect evidence for the MAP
kinase cascade-inducing capacity of SmTK4 in Xenopus oocytes,
Y2/3H analyses identified its interactions with the Src kinases
SmTK6 and SmTK3 as upstream partners as well as with a
MAPK-activating protein as one of two candidate downstream
partner. Since Src kinases are activated by RTKs, it seems feasible
to us that in S. mansoni oocytes the signal is transduced from a
RTK to a Src kinase leading to the activation of the Syk kinase
SmTK4, which in turn activates a MAPK cascade.
Its essential function for gonad development and the long-term
killing effect of worms by Piceatannol in culture suggest that
SmTK4 may be a candidate target for blocking transmission and
disease progression. Although CTKs such as Syk kinases are
conserved in the animal kingdom, there may be possibilities to
target specific homologs. A comparison of human Syk (accession
number AAH11399) and SmTK4 (accession number CAD13249)
revealed differences at the amino acid level between 17% (within
the catalytic domain) and 63% (whole protein). This and the
remarkable elongated linker-domain region of SmTK4 may
provide a basis for selective drug design.
Materials and Methods
Ethics statement
All experiments involving hamsters within this study have been
performed in accordance with the European Convention for the
Protection of Vertebrate Animals used for Experimental and other
Scientific Purposes (ETS No 123; revised Appendix A) and have
been approved by the Regional Council (Regierungspraesidium)
Giessen (V54-19 c 20/15 c GI 18/10).
Yeast two-/three-hybrid screening
A Y2H cDNA-library based on RNA of adult male and female
S. mansoni was constructed [33]. To this end, cDNAs were cloned
into the prey vector pGADT7-Rec (leucine nutritional marker
LEU2, Clontech) in frame with the GAL4 activation domain
(Gal4-AD). For subsequent library screening, mating was per-
formed according to the user manual (Yeast protocols handbook,
Clontech). Two yeast strains were used for the mating; the library-
containing strain AH109 (Mat a; reporter genes ADE2, HIS3, and
LacZ) and the bait-containing strain Y187 (Mat a; reporter genes
HIS3, LacZ). As bait vector for library screening, the plasmid
pBridge (tryptophan nutritional marker TRP1, Clontech) was
used, which contains two multiple cloning sites, MCS I and MCS
II. MCS I allows the cloning of protein-coding gene sequences as
fusion constructs with the GAL4 DNA binding domain (Gal4-BD).
MCS II permits the cloning of a second gene sequence for the
expression of an additional protein and, therefore, allows the
establishment of a Y3H system.
Cloning of the bait vectors
Screening for upstream interaction partners of SmTK4 was
performed with a bait vector containing the tandem SH2-domain
of SmTK4 cloned into the MCS I in frame with the GAL4 DNA-
binding domain (Gal4-BD). The encoding sequence was amplified
by PCR using the SmTK4-specific primer pair SmTK4-SH2SH2-
59 (59-GGATCCGTGGAGCTATTCCAC-39; containing a
BamHI restriction site) and SmTK4-SH2SH2-39 (59-CTGCAGT-
GATATACCACCGGA-39; containing a PstI restriction site), and
a full-length cDNA clone of SmTK4 as template. Amplification
products of the expected size were cloned via BamHI/PstI into the
MCS I of the vector pBridge. After cloning, the resulting construct
SmTK4-SH2SH2 pBridge was sequenced to confirm the correct
open reading frame of the Gal4-BD/SmTK4-SH2SH2 fusion. To
perform a Y3H screening for upstream binding partners of
SmTK4 a second bait vector was constructed, containing
SmTK4-SH2SH2 in the MCS I and, additionally, the coding
sequence for the TK domain of the schistosome Src kinase
SmTK3 in the MCS II. To this end, the sequence for the SmTK3
TK-domain was amplified by PCR using the SmTK3-specific
primers SmTK3-TK-59 (59-GCGGCCGCATCATCCAGAAC-
CTGTGGG-39; containing a BglII restriction site) and SmTK3-
TK-39 (59-AGATCTGCTGGTTGCTCATCTTCAC-39; con-
taining a NotI restriction site), and a full-length cDNA clone of
SmTK3 as template. The PCR product was cloned via BglII/NotI
into the MCS II of SmTK4-SH2SH2 pBridge resulting in the
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of this cloning approach was confirmed by sequencing. For control
studies to test binding specificities, modified versions of this
construct were additionally cloned by deletion of either the
N-terminal or the C-terminal SH2-domain of SmTK4 (SmTK4-
SH2(1) + SmTK3-TK pBridge, SmTK4-SH2(2) + SmTK3-
TK pBridge).
To screen for downstream interaction partners of SmTK4 three
different bait vectors were constructed, containing either the
linker-region of SmTK4, the linker-region and the TK domain, or
only the TK domain of SmTK4 in the MCS I. The coding
sequences of these regions of SmTK4 were amplified by PCRs
with the primer pairs TK4-bait1-59 (59-GGATCCTACAGAAAC-
CAATACCAGTATC-39) + TK4-bait1-39 (59-CTGCAGGGTA-
TGCAAATATTTGTTTGT-39), TK4-bait1-59 + TK4-bait2-39
(59-CTGCAGTTCAACAAGAAATTCGATG-39), or TK4-bait2-
59 (59-GGATCCAAATTTATGATGAATTACCACC-39) + TK4-
bait2-39, respectively, and a full-length cDNA clone of SmTK4 as
template. The 59-primers contained a BamHI restriction site and the
39-primers a PstI restriction site, respectively. Amplification products
of the expected sizes were cloned via BamHI/PstIi nt h eM C SIo f
pBridge in frame with the Gal4-BD, resulting in the constructs
SmTK4-linker+TK pBridge, SmTK4-linker pBridge, and SmTK4-
TK pBridge. For Y3H analysis, an additional vector was
constructed, containing the SmTK4 linker region and TK domain
in the MCS I, and the SmTK3 TK-domain in the MCS II
(SmTK4-linker+TK + SmTK3-TK pBridge). The integrity of the
open reading frames with the Gal4-BD was confirmed by
sequencing.
Screening of the yeast two-hybrid library
The screening for upstream or downstream interaction partners
of SmTK4 was performed with either the bait construct SmTK4-
SH2SH2 + SmTK3-TK pBridge or SmTK4-linker+TK +
SmTK3-TK pBridge, respectively. Yeast cells (strain Y187) were
individually transformed with both plasmids by the lithium acetate
method (Yeast protocols handbook, Clontech). For the screening
of the S. mansoni library, bait-expressing Y187 cells were mated
with library-containing AH109 cells. Mating efficiencies of 75% or
28% were obtained, respectively, which exceeded the required
minimum of 2% in both cases (Clontech). The first selection of
diploid yeast cells containing interacting proteins was carried out
on synthetic dropout medium lacking the amino acids tryptophan,
leucine, and histidine (Trp
2/Leu
2/His
2). To enhance the
selection pressure on clones with interacting proteins, grown
colonies were plated onto synthetic dropout medium lacking the
amino acids tryptophan, leucine, histidine, and adenine (Trp
2/
Leu
2/His
2/Ade
2). For further selection, b-Gal colony filter
assays were performed using X-Gal as substrate according to the
manufacturer’s instructions (Yeast protocols handbook, Clontech).
From positively tested yeast clones, plasmid DNA was isolated
using cell disruption by vortexing with glass beads (Sigma) followed
by plasmid preparation (PeqLab). Isolated plasmid DNA was
transformed into heat shock-competent Escherichia coli cells
(DH5a), and the bacteria selected on LB-plates containing
ampicillin (100 mg/ml). To differentiate bacterial colonies contain-
ing the pBridge bait-plasmid from those containing a pGADT7
prey-plasmid, colony PCRs with pGADT7-specific primers were
performed. Prey plasmids from PCR-positive bacterial clones were
isolated and sequenced commercially (AGOWA, Berlin). For
further binding analyses, the yeast strain AH109 was transformed
with appropriate prey plasmids together with different bait
plasmids. To confirm protein-protein interactions, the selection
procedures were repeated. For quantification of relative interac-
tion strengths, b-Gal liquid assays with ONPG (o-nitrophenol-
galactopyranoside, SIGMA) as substrate were performed accord-
ing to the Yeast protocols handbook from Clontech.
Isolation of RNA and proteins from yeast
For isolation of yeast total RNA, a 5 ml overnight culture of the
appropriate yeast clone was centrifuged to harvest cells. The pellet
was washed two times with PBS and afterwards frozen in liquid
nitrogen. Cells were disrupted by three freeze/thaw cycles (liquid
nitrogen, 37uC water bath), 1 ml TriFast (PeqLab) was then added
to the cell lysate, and total RNA was extracted according to the
manufacturer’s instructions.
Total protein extracts from yeast cells were obtained using the
urea/SDS method as described in the Yeast protocols handbook
(Clontech). For the inhibition of endogenous proteases and
phosphatases, the buffer for cell disruption was supplemented
with PMSF (phenylmethylsulfonylfluoride, SIGMA), protease
inhibitor cocktail (Complete Mini, Roche), NaF (sodium fluoride,
50 mM), and Na3VO4 (sodium orthovanadate, 2 mM). Protein
extracts were analyzed by standard SDS-PAGE and Western
blotting with an anti-phosphotyrosine-specific antibody (Santa
Cruz Biotechnology).
RT-PCR analyses of yeast transcripts
To confirm the transcription of the different bait-constructs
inside the yeasts, RT-PCRs were performed with total RNA from
bait-containing yeast clones as template. RT-PCRs were carried
out stepwise in two separate reactions. First, 90 ng of total RNA
was converted into cDNA using the SensiScript reverse transcrip-
tase (Qiagen) and oligo-d(T), or bait sequence-specific primers.
One fourth of the RT reaction volume was used for
PCR amplification using appropriate bait sequence-specific
primers. Amplification products were analyzed by agarose gel
electrophoresis.
Co-immunoprecipitation
The pESC-His yeast expression system (Novagen) was used for
immunoprecipitation experiments. The pESC-His vector con-
tains two multiple cloning sites (MCS I, contains a FLAG-tag
sequence; MCS II contains a cMyc-tag sequence) under the
control of galactose-inducible GAL10 or GAL1 promoters. The
tandem SH2-domain of SmTK4 was cloned into MCS I (FLAG-
tag at the C-terminus), and the nearly complete version of
SmTK6 (except 250 bp of the N-terminus) was cloned into MCS
II (cMyc-tag at the N-terminus). For cloning, the tandem SH2-
domain of SmTK4 was amplified by PCR using gene-specific
primers containing appropriate restriction sites (TK4-SH2SH2-
pESC-His-59(NotI): 59-GCGGCCGCAATGGGAGCTATTC-
CACCG-39; TK4-SH2SH2-pESC-His-39(ClaI): 59-ATCGAT-
GATATACCACCGGAACCTGA-39). Before cloning into MCS
II, the SmTK6 sequence was also PCR-amplified using gene-
specific primers with restriction sites (TK6-Voll-pESC-His-
59(XhoI): 59-CTCGAGAATGTTGTGACTGATGTGCAT-39;
TK6-Voll-pESC-His-39(SacII): 59-CCGCGGTTATCTAAATA-
TTGAGCTTCTGTGTGC-39). The integrity of the cloned
constructs was confirmed by sequencing (AGOWA, Germany).
Following transformation, yeast cells (strain YPH501) were
grown for 5 days at 30uC on selection media (synthetic drop-out
medium [SD], His
2, + glucose) to ensure the presence of the
vector. Selected clones were grown over night in SD (His
2, +
glucose) liquid medium. The cells were centrifuged the next day
and resuspendend in SG medium (His
2, + galactose) and
incubated for 5 h to induce transgene expression. As control,
SmTK4 of S. mansoni
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(His
2, + glucose). Protein was isolated from 10 ml culture volume
for electrophoresis (10 mg protein each; 10% SDS-PAGE). After
blotting on nitrocellulose (Schleicher & Schu ¨ll) the induction of
the expression of the recombinant schistosome proteins was
confirmed by Western-blot analysis using an anti-FLAG-tag
(2.5 mg/ml; Novagen) or an anti-cMyc-tag antibodies (1 mg/ml;
Novagen). A goat anti-rabbit-HRP (horse raddish peroxidase)
secondary antibody was used for detection (1:70.000; Novagen).
Individual bands of the expected sizes of 31 kDa (SmTK4-
SH2SH2) or 55 kDa (SmTK6) were observed in proteins
obtained from the galactose-induced yeast culture but not in
proteins obtained from the glucose-induced culture (results not
shown).
For co-IP 70 ml of the protein lysate of the galactose-induced
culture were pre-incubated with 30 ml protein A sepharose (Sigma)
to remove proteins binding unspecifically. The remaining lysate
was splitted in two parts, and each half incubated (over night at
4uC) with 4 mg anti-FLAG-tag antibody or 1 mg anti-cMyc-tag
antibody, respectively. Antibody complexes were precipitated by
protein A sepharose (2 h at 4uC). Following washing steps, the
protein complexes were eluated from the protein A sepharose, and
a Western-blot analysis was done with the recovered yeast protein
as described above. After nitrocellulose transfer, the proteins were
visualized by INDIA ink staining (Pelikan, Germany; 1% acetic
acid, 0.04% Tween 20, 0.1% Fount India).
Transcription analyses of schistosome genes
To monitor the transcription of SmTK4 in control and treated
S. mansoni, total RNA was extracted using TriFast (PeqLab)
following the manufacturer’s instructions. Residual DNA remain-
ing in the RNA preparations was removed by DNase digestion
using RNase-free DNaseI (Fermentas). cDNA was synthesized
using 1 mg total RNA, 1 ml oligo-d(T) primer (dT24VN; 20 mM),
1 ml nonamer primer (dN9;2 0mM) and Superscript II reverse
transcriptase (Invitrogen). Subsequent PCRs were performed with
1/10 of the cDNA as template, FIREPol Taq polymerase (Solis
BioDyne), and the following primer combination: SmTK4-
Sub3-59 (59-ATGACGTAAAAGATTCACGTG-39)a n dS m T K 4 -
Sub3-39 (59-TGCATGTTCTTCACTACAATC-39), which flank
the region used as target for the dsRNAs. For normalization, the
transcription of the housekeeping gene SmPDI [48] was monitored
using the same cDNAs as template, but using the following primer
combination: SmPDI-59 (59-GGGATTTATCAAGGATACG-
GACTC-39)a n dS m P D I - 3 9 (59-CACCAAGGAGCATACAGTTT-
GAC-39). All PCRs were performed in a final volume of 25 ml. PCR
products were separated on 1.5% agarose gels stained with ethidium
bromide. The relative intensities of the amplification products were
determined densitometrically using the program ImageJ (version
1.4.1; http://rsbweb.nih.gov/ij/index.html). For relative quantifica-
tion of the SmTK4 products, the SmPDI products were used as
endogenous standard.
In situ hybridizations were done as described elsewhere in detail
[31,33]. In short, adult worm pairs were fixed in Bouin’s solution
(picric acid/acetic acid/formaldehyde; 15/1/5) before embedding
in paraplast (Histowax, Reichert-Jung). Sections of 5 mm were
generated and incubated in xylol to remove the paraplast.
Following re-hydration, proteins were removed by proteinase K
treatment (final concentration 1 mg/ml), and the sections were
dehydrated. For hybridization, in vitro transcripts were labeled with
digoxigenin following the manufacturers’ instructions (Roche).
Labeled sense and antisense transcripts of SmTK6 (unique site,
length 354 bp), the MAPK activating protein PM20/21 (length
452 bp), or mapmodulin (length 420 bp), were size-controlled by
gel electrophoresis. To prove their quality, transcript blots were
made to confirm digoxigenin incorporation by alkaline phospha-
tase-conjugated anti-digoxigenin antibodies, naphthol-AS-phos-
phate, and Fast Red TR (Sigma). All in situ hybridization were
performed for 16 h at 42uC. Sections were stringently washed up
to 0.56SSC, and detection was achieved as described for
transcript blots.
Parasite stock
A Liberian isolate of S. mansoni was maintained in Biomphalaria
glabrata as intermediate host and in Syrian hamsters (Mesocricetus
auratus) as definitive host [83]. Adult worms were obtained by
hepatoportal perfusion at 42–49 days post-infection.
In vitro culture of adult schistosomes
After perfusion, adult schistosomes were washed three times
with M199 medium before being cultured in vitro in M199 (Gibco;
including glucose, sodium bicarbonate, 4-(2-hydroxyethyl)-1-
piperazineethane sulfonic acid) supplemented with an antibiotic/
antimycotic mixture (1.25%, Sigma) and FCS (10%, Gibco) at
37uC and 5% CO2 [42]. For each experiment, 10–30 pairs of S.
mansoni were kept in 60 mm diameter culture dishes in 3 ml
culture medium. The medium was changed every 24 hours. If
needed, schistosome pairs were carefully separated with fine
tweezers.
Inhibitor treatment and morphological analysis
Piceatannol (3,4,39,59-Tetrahydroxy-trans-stilbene; Alexis Bio-
chemicals) was dissolved in dimethyl sulfoxide (DMSO) (5 mg/ml).
For each inhibitor treatment experiment 20 adult couples of S.
mansoni were maintained in 10 ml culture medium [42],
supplemented with various concentrations of Piceatannol
(35 mM, 70 mM, 100 mM). Medium and inhibitor were refreshed
every 24 hours during the treatment periods in vitro. For
morphological analysis, adult worms were fixed for at least
24 hours in AFA (alcohol 95%, formalin 3%, and glacial acetic
acid 2%), stained for 30 minutes with 2.5% hydrochloric carmine
(CertistainH, Merck), and destained in acidic 70% ethanol. After
dehydration for 5 minutes in 70%, 90%, and 100% ethanol,
respectively, worms were preserved as whole-mounts in Canada
balsam (Merck) on glass slides [43,44]. CLSM images were made
on a Leica TSC SP2 microscope using a 488 nm He/Ne laser and
a 470 nm long-pass filter in reflection mode.
RNAi experiments
As basis for double-stranded RNA (dsRNA) synthesis, a 813 bp
fragment of the SmTK4-coding DNA was amplified by PCR using
the gene-specific primers SmTK4-59 (59-ATGCCTGGAGC-
TATTCCA-39) and SmTK4-39 (59-TGATATACCACCGGA-
39) and a full-length cDNA clone of SmTK4 as template. The
amplification product of expected size was cloned into the pDrive
cloning vector (Qiagen). The resulting construct, containing T7
and SP6 RNA polymerase promoters flanking the SmTK4
sequence was used to generate single-stranded RNA by in vitro
transcription with T7 and SP6 RNA polymerases (MEGAscript
RNA transcription kit, Ambion). The single-stranded RNAs were
purified by LiCl-precipitation, resuspended in dH2O, and
quantified by spectrophotometry. Equal amounts of the single-
stranded RNAs were mixed in annealing buffer (500 mM
potassium acetate, 150 mM HEPES-KOH, pH 7.4, 19 mM
magnesium acetate, sterile dH2O) and incubated at 68uC for
15 min. Annealing and integrity of the dsRNAs were confirmed by
agarose gel electrophoresis.
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electroporation protocol of Correnti et al. [84] and Ndegwa et al.
[47]. Briefly, electroporations were performed in 4 mm cuvettes
with 10 couples in 50 ml electroporation buffer (Ambion)
containing 25 mg dsRNA. A square-wave protocol was applied
with a single 20 ms impulse at 125 V and at room temperature
(Gene Pulser XCell
TM, Biorad). After electroporation, the worms
were transferred to complete M199 medium and incubated for 5
days; 48 hours after electroporation the medium was refreshed.
Xenopus oocyte transfection and inhibitor studies
Capped messenger RNA (cRNA) encoding the full-length
cDNA of SmTK4 or a shortened variant containing the catalytic
TK domain of SmTK4 was synthesized in vitro using the T7
mMessage mMachine Kit (Ambion, USA). Following synthesis,
cRNA was injected into stage VI oocytes according to previously
published protocols [50,85]. To investigate Piceatannol effects,
transfected oocytes were incubated with increasing concentrations
(1, 2, 5, 10, 20, 50, or 100 mM) of Piceatannol. Non-injected
control oocytes were incubated with the same inhibitor concen-
trations. As positive control progesterone was used, a steroid
known to induce germinal vesicle break down (GVBD) in Xenopus
oocytes [49]. This oocyte-specific physiological activity was
detected by the appearance of a white spot at the center of the
animal pole.
In silico analysis
The following public domain tools were used for sequence
analyses: NCBI-BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi),
the Wellcome Trust Sanger Institute S. mansoni OmniBlast server
(http://www.sanger.ac.uk/cgi-bin/blast/submitblast/s_mansoni/
omni), and GeneDB (http://www.genedb.org). For BLAST
analyses to identify Syk kinases in the schistosome genome data
set [6] we used the kinase domain sequence as template as the
most conserved part of tyrosine kinases.
Supporting Information
Figure S1 Influence of dsRNA treatment of S. mansoni couples
on SmTK4-transcript level in adults. To post transcriptionally
inhibit SmTK4 by RNAi, 10 worm couples each were either
electroporated without dsRNA (control), with SmTK4-specific
dsRNAs (1–3), or with SmTK3-specific dsRNAs (4). The amount
of SmTK4 transcripts was analyzed compared to the amount of
transcripts from the housekeeping gene SmPDI. In three
independent experiments using SmTK4-specific dsRNAs the
SmTK4 transcript level was reduced to 10–32% that of the
controls. The statistical evaluation of three densitometric mea-
surements is shown (error bars are indicated). Student’s t-test (two-
tailed): *p,0.001.
Found at: doi:10.1371/journal.ppat.1000769.s001 (1.73 MB
TIF)
Table S1 Y2H interaction analyses to investigate the binding
capacity of potential upstream binding partners to the tandem
SH2-domain of SmTK4. Yeast cells (strain AH109) were
transformed with individual prey plasmids and plasmids contain-
ing the individual N-terminal SH2(1) or C-terminal SH2(2)
domain of SmTK4 (within the MCS I) and SmTK3 TK (within
the MCS II), or the original bait plasmid SmTK4 SH2SH2 +
SmTK3 TK pBridge, which contained both SH2 domains
(tandem SH2-domain). All clones were first selected for the
presence of the plasmids (Trp-/Leu-), and then for interaction
(Trp-/Leu-/Ade-/His-). [+/2, growth indication: clones surviv-
ing/not surviving selection for interaction]
Found at: doi:10.1371/journal.ppat.1000769.s002 (0.03 MB
DOC)
Table S2 GVBD assay to determine SmTK4 activity and its
suppression by Piceatannol. cRNAs encoding the full-length
SmTK4 cDNA or a shortened variant containing only the
catalytic TK domain of this kinase were injected into stage VI
oocytes of Xenopus laevis according to previously published
protocols [50,51,84]. Piceatannol effects on germinal vesicle break
down (GVBD; [49,70]) were investigated by adding increasing
concentrations of this inhibitor (1, 2, 5, 10, 20, 50, or 100 mM).
GVBD was evaluated microscopically by the appearance of a
white spot at the center of the animal pole. As negative control,
non-injected oocytes were incubated with the same inhibitor
concentrations. As positive control, progesterone was used, a
steroid known to induce GVBD in Xenopus oocytes [49,70].
Found at: doi:10.1371/journal.ppat.1000769.s003 (0.03 MB
DOC)
Acknowledgments
We thank Gabriele Lang, Christine Henrich, Christina Scheld, and Stefan
Sroka for valuable technical assistance. The authors also thank Dr. Katia
Cailliau and Dr. Edith Browaeys (Universite ´ des Sciences et Technologies
de Lille, France) for providing stage VI oocytes and for their expertise in
oocyte manipulation. The authors highly appreciate the enormous amount
of schistosome genome data provided by The Wellcome Trust Sanger
Institute (http://www.sanger.ac.uk). Furthermore, the authors thank Dr.
Roger Dennis for critically reading the manuscript.
Author Contributions
Conceived and designed the experiments: CGG. Performed the experi-
ments: SB CB CD JH. Analyzed the data: SB CB CD. Contributed
reagents/materials/analysis tools: CD. Wrote the paper: SB CGG.
References
1. Chitsulo L, LoVerde PT, Engels D (2004) Schistosomiasis. Nat Rev Microbiol 2:
12–13.
2. Quack T, Beckmann S, Grevelding CG (2006) Schistosomiasis and the
molecular biology of the male-female interaction of S. mansoni. BMTW 119:
365–372.
3. Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, et al. (2002) Schistosomiasis.
N Engl J Med 346: 1212–1220.
4. McManus DP, Loukas A (2008) Current status of vaccines for schistosomiasis.
Clin Microbiol Rev 21: 225–242.
5. Fenwick A, Webster JP (2006) Schistosomiasis: challenges for control, treatment
and drug resistance. Curr Opin Infect Dis 19: 577–582.
6. Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, et al. (2009) The
genome of the blood fluke Schistosoma mansoni. Nature 460: 352–358.
7. The Schistosoma japonicum Genome Sequencing and Functional Analysis
Consortium (2009) The Schistosoma japonicum genome reveals features of host–
parasite interplay. Nature 460: 345–351.
8. Oliveira G (2007) The Schistosoma mansoni transcriptome: An update. Exp
Parasitol 117: 229–235.
9. van Hellemond JJ, van Balkom BW, Tielens AG (2007) Schistosome biology and
proteomics: progress and challenges. Exp Parasitol 117: 267–274.
10. Hokke CH, Deelder AM, Hoffmann KF, Wuhrer M (2007) Glycomics-driven
discoveries in schistosome research. Exp Parasitol 117: 275–283.
11. Kunz W (2001) Schistosome male-female interaction: induction of germ-cell
differentiation. Trends Parasitol 17: 227–231.
12. Erasmus DA (1973) A comparative study of the reproductive system of mature,
immature and ‘‘unisexual’’ female Schistosoma mansoni. Parasitology 67: 165–183.
13. LoVerde PT, Niles EG, Osman A, Wu W (2004) Schistosoma mansoni male-female
interactions. Canadian Journal of Zoology 82: 357–374.
14. Popiel I (1986) Male-stimulated female maturation in Schistosoma: a review.
J Chem Ecol 12: 1745–1754.
15. Moore DV, Sandground JH (1956) The relative egg producing capacity of
Schistosoma mansoni and Schistosoma japonicum. Am J Trop Med Hyg 5: 831–840.
SmTK4 of S. mansoni
PLoS Pathogens | www.plospathogens.org 15 February 2010 | Volume 6 | Issue 2 | e100076916. LoVerde PT, Osman A, Hinck A (2007) Schistosoma mansoni: TGF-beta signaling
pathways. Exp Parasitol 117: 304–317.
17. Knobloch J, Beckmann S, Burmeister C, Quack T, Grevelding CG (2007)
Tyrosine kinase and cooperative TGFbeta signaling in the reproductive organs
of Schistosoma mansoni. Exp Parasitol 117: 318–336.
18. Knobloch J, Winnen R, Quack M, Kunz W, Grevelding CG (2002) A novel Syk-
family tyrosine kinase from Schistosoma mansoni which is preferentially transcribed
in reproductive organs. Gene 294: 87–97.
19. Ferrante AW, Reinke R, Stanley ER (1995) Shark, a Src homology 2, ankyrin
repeat, tyrosine kinase, is expressed on the apical surfaces of ectodermal
epithelia. Proc Natl Acad Sci USA 92: 1911–1915.
20. Steele RE, Stover NA, Sakaguchi M (1999) Appearance and disappearance of
Syk family protein-tyrosine kinase genes during metazoan evolution. Gene 239:
91–97.
21. Page TH, Smolinska M, Gillespie J, Urbaniak AM, Foxwell BM (2009) Tyrosine
kinases and inflammatory signalling. Curr Mol Med 9: 69–85.
22. Yanagi S, Inatome R, Takano T, Yamamura H (2001) Syk expression and novel
function in a wide variety of tissues. Biochem Biophys Res Commun 288:
495–498.
23. Coopman PJ, Mueller SC (2006) The Syk tyrosine kinase: a new negative
regulator in tumor growth and progression. Cancer Lett 241: 159–173.
24. Fluck M, Zurcher G, Andres AC, Ziemiecki A (1995) Molecular characterization
of the murine syk protein tyrosine kinase cDNA, transcripts and protein.
Biochem Biophys Res Commun 213: 273–281.
25. Inatome R, Yanagi S, Takano T, Yamamura H (2001) A critical role for Syk in
endothelial cell proliferation and migration. Biochem Biophys Res Commun
286: 195–199.
26. Tsujimura T, Yanagi S, Inatome R, Takano T, Ishihara I, et al. (2001) Syk
protein-tyrosine kinase is involved in neuron-like differentiation of embryonal
carcinoma P19 cells. FEBS Lett 489: 129–133.
27. Geahlen RL (2007) Syk. UCSD-Nature Molecule Pages, doi:10 1038/mp
a000040 01.
28. Ottinger EA, Botfield MC, Shoelson SE (1998) Tandem SH2 domains confer
high specificity in tyrosine kinase signaling. J Biol Chem 273: 729–735.
29. Pawson T, Kofler M (2009) Kinome signaling through regulated protein-
protein interactions in normal and cancer cells. Curr Opin Cell Biol 21:
147–153.
30. Geahlen RL (2009) Syk and pTyr’d: Signaling through the B cell antigen
receptor. Biochim Biophys Acta, doi:10 1016/j bbamcr 2009 03 004.
31. Kapp K, Knobloch J, Schussler P, Sroka S, Lammers R, et al. (2004) The
Schistosoma mansoni Src kinase TK3 is expressed in the gonads and likely involved
in cytoskeletal organization. Mol Biochem Parasitol 138: 171–182.
32. Kapp K, Schussler P, Kunz W, Grevelding CG (2001) Identification, isolation
and characterization of a Fyn-like tyrosine kinase from Schistosoma mansoni.
Parasitology 122: 317–327.
33. Quack T, Knobloch J, Beckmann S, Vicogne J, Dissous C, et al. (2009) The
formin-homology protein SmDia interacts with the Src kinase SmTK3 and the
GTPase SmRho1 in the gonads of Schistosoma mansoni. PLoS ONE 4: e6998.
doi:10.1371/journal.pone.0006998.
34. Oliver JM, Burg DL, Wilson BS, McLaughlin JL, Geahlen RL (1994) Inhibition
of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-
selective inhibitor, Piceatannol. J Biol Chem 269: 29697–29703.
35. Geahlen RL, McLaughlin JL (1989) Piceatannol (3,4,39,59-tetrahydroxy-trans-
stilbene) is a naturally occurring protein-tyrosine kinase inhibitor. Biochem
Biophys Res Commun 165: 241–245.
36. Ptacek J, Devgan G, Michaud G, Zhu H, Zhu X, et al. (2005) Global analysis of
protein phosphorylation in yeast. Nature 438: 679–684.
37. Marengere LE, Pawson T (1994) Structure and function of SH2 domains. J Cell
Sci Suppl 18: 97–104.
38. Osborne MA, Dalton S, Kochan JP (1995) The yeast tribrid system-genetic
detection of trans-phosphorylated ITAM-SH2-interactions. Biotechnology (NY)
13: 1474–1478.
39. Wang B, Lemay S, Tsai S, Veillette A (2001) SH2 domain-mediated interaction
of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-
HSCF. Mol Cell Biol 21: 1077–1088.
40. Shokat KM (1995) Tyrosine kinases: modular signaling enzymes with tunable
specificities. Chem Biol 2: 509–514.
41. Moon KD, Post CB, Durden DL, Zhou Q, De P, et al. (2005) Molecular basis
for a direct interaction between the Syk protein-tyrosine kinase and
phosphoinositide 3-kinase. J Biol Chem 280: 1543–1551.
42. Knobloch J, Kunz W, Grevelding CG (2006) Herbimycin A suppresses mitotic
activity and egg production of female Schistosoma mansoni. Int J Parasitol 36:
1261–1272.
43. Machado-Silva JR, Pelajo-Machado M, Lenzi HL, Gomes DC (1998)
Morphological study of adult male worms of Schistosoma mansoni Sambon, 1907
by confocal laser scanning microscopy. Mem Inst Oswaldo Cruz 93 Suppl 1:
303–307.
44. Neves RH, de Lamare BC, Machado-Silva JR, Carvalho JJ, Branquinho TB,
et al. (2005) A new description of the reproductive system of Schistosoma mansoni
(Trematoda: Schistosomatidae) analyzed by confocal laser scanning microscopy.
Parasitol Res 95: 43–49.
45. Willeke T, Schymeinsky J, Prange P, Zahler S, Walzog B (2003) A role for Syk-
kinase in the control of the binding cycle of the beta2 integrins (CD11/CD18) in
human polymorphonuclear neutrophils. J Leukoc Biol 74: 260–269.
46. Gresson RAR (1964) Electron microscopy of the ovary of Fasciola hepatica.
Quart J micro Sci 105: 213–218.
47. Ndegwa D, Krautz-Peterson G, Skelly PJ (2007) Protocols for gene silencing in
schistosomes. Exp Parasitol 117: 284–291.
48. Finken M, Sobek A, Symmons P, Kunz W (1994) Characterization of the
complete protein disulfide isomerase gene of Schistosoma mansoni and identifica-
tion of the tissues of its expression. Mol Biochem Parasitol 64: 135–144.
49. Hirai S, Le Goascogne C, Baulieu EE (1983) Induction of germinal vesicle
breakdown in Xenopus laevis oocytes: response of denuded oocytes to progesterone
and insulin. Dev Biol 100: 214–221.
50. Vicogne J, Cailliau K, Tulasne D, Browaeys E, Yan Y, Fafeur V, Vilain JP,
Legrand D, Trolet J, Dissous C (2004) Conservation of epidermal growth factor
receptor function in the human parasitic helminth Schistosoma mansoni. J Biol
Chem 279: 37407–37414.
51. Yan Y, Tulasne D, Browaeys E, Cailliau K, Khayath N, Pierce RJ, Trolet J,
Fafeur V, Ben Younes A, Dissous C (2007) Molecular cloning and
characterisation of SmSLK, a novel Ste20-like kinase in Schistosoma mansoni.
Int J Parasitol 37: 1539–1550.
52. Wilkinson MF (2003) The cycle of nonsense. Mol Cell 12: 1059–1061.
53. Baral PK, Jajcanin-Jozic N, Deller S, Macheroux P, Abramic M, et al. (2008)
The first structure of dipeptidyl-peptidase III provides insight into the catalytic
mechanism and mode of substrate binding. J Biol Chem 283: 22316–22324.
54. Kurosaki T, Takata M, Yamanashi Y, Inazu T, Taniguchi T, et al. (1994) Syk
activation by the Src-family tyrosine kinase in the B cell receptor signaling. J Exp
Med 179: 1725–1729.
55. Arias-Salgado EG, Lizano S, Sarkar S, Brugge JS, Ginsberg MH, et al. (2003)
Src kinase activation by direct interaction with the integrin beta cytoplasmic
domain. Proc Natl Acad Sci U S A 100: 13298–13302.
56. Furlong MT, Mahrenholz AM, Kim KH, Ashendel CL, Harrison ML, et al.
(1997) Identification of the major sites of autophosphorylation of the murine
protein-tyrosine kinase Syk. Biochim Biophys Acta 1355: 177–190.
57. Budd RC (2001) Activation-induced cell death. Curr Opin Immunol 13:
356–362.
58. Zhong L, Wu CH, Lee WH, Liu CP (2004) Zeta-associated protein of 70 kDa
(ZAP-70), but not Syk, tyrosine kinase can mediate apoptosis of T cells through
the Fas/Fas ligand, caspase-8 and caspase-3 pathways. J Immunol 172:
1472–1482.
59. Zhou F, Hu J, Ma H, Harrison ML, Geahlen RL (2006) Nucleocytoplasmic
trafficking of the Syk protein tyrosine kinase. Mol Cell Biol 26: 3478–3491.
60. Calderwood SK, Mambula SS, Gray PJ Jr, Theriault JR (2007) Extracellular
heat shock proteins in cell signaling. FEBS Lett 581: 3689–3694.
61. Castro JE, Prada CE, Loria O, Kamal A, Chen L, et al. (2005) ZAP-70 is a novel
conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to
ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic
leukemia. Blood 106: 2506–2512.
62. Opal P, Garcia JJ, Propst F, Matilla A, Orr HT, et al. (2003) Mapmodulin/
leucine-rich acidic nuclear protein binds the light chain of microtubule-
associated protein 1B and modulates neuritogenesis. J Biol Chem 278:
34691–34699.
63. Ulitzur N, Humbert M, Pfeffer SR (1997) Mapmodulin: a possible modulator of
the interaction of microtubule-associated proteins with microtubules. Proc Natl
Acad Sci U S A 94: 5084–5089.
64. Peters JD, Furlong MT, Asai DJ, Harrison ML, Geahlen RL (1996) Syk,
activated by cross-linking the B-cell antigen receptor, localizes to the cytosol
where it interacts with and phosphorylates alpha-tubulin on tyrosine. J Biol
Chem 271: 4755–4762.
65. Faruki S, Geahlen RL, Asai DJ (2000) Syk-dependent phosphorylation of
microtubules in activated B-lymphocytes. J Cell Sci 113 (Pt 14): 2557–2565.
66. Bluthgen N, Legewie S (2008) Systems analysis of MAPK signal transduction.
Essays Biochem 45: 95–107.
67. Raman M, Chen W, Cobb MH (2007) Differential regulation and properties of
MAPKs. Oncogene 26: 3100–3112.
68. Sada K, Takano T, Yanagi S, Yamamura H (2001) Structure and function of
Syk protein tyrosine kinases. J Biochem 130: 177–186.
69. Spiliotis M, Konrad C, Gelmedin V, Tappe D, Bruckner S, Mosch HU,
Brehm K (2006) Characterisation of EmMPK1, an ERK-like MAP kinase from
Echinococcus multilocularis which is activated in response to human epidermal
growth factor. Int J Parasitol 36: 1097–1112.
70. Kosako H, Gotoh Y, Nishida E (1994) Requirement for the MAP kinase kinase/
MAP kinase cascade in Xenopus oocyte maturation. EMBO J 13: 2131–2138.
71. Mansir A, Justine JL (1998) The microtubular system and posttranslationally
modified tubulin during spermatogenesis in a parasitic nematode with amoeboid
and aflagellate spermatozoa. Mol Reprod Dev 49: 150–167.
72. Sun QY, Schatten H (2006) Regulation of dynamic events by microfilaments
during oocyte maturation and fertilization. Reproduction 131: 193–205.
73. Xiao X, Yang WX (2007) Actin-based dynamics during spermatogenesis and its
significance. J Zhejiang Univ Sci B 8: 498–506.
74. Bellier S, Dubois MF, Nishida E, Almouzni G, Bensaude O (1997)
Phosphorylation of the RNA polymerase II largest subunit during Xenopus laevis
oocyte maturation. Mol Cell Biol 17: 1434–1440.
75. Jiang K, Zhong B, Gilvary DL, Corliss BC, Vivier E, et al. (2002) Syk regulation
of phosphoinositide 3-kinase-dependent NK cell function. J Immunol 168:
3155–3164.
SmTK4 of S. mansoni
PLoS Pathogens | www.plospathogens.org 16 February 2010 | Volume 6 | Issue 2 | e100076976. Braydich-Stolle L, Kostereva N, Dym M, Hofmann MC (2007) Role of Src
family kinases and N-Myc in spermatogonial stem cell proliferation. Dev Biol
304: 34–45.
77. Kierszenbaum AL (2006) Tyrosine protein kinases and spermatogenesis:
truncation matters. Mol Reprod Dev 73: 399–403.
78. Beckmann S, Quack T, Burmeister C, Buro C, Long T, Dissous C,
Grevelding CG (2010) Schistosoma mansoni: Signal transduction processes during
the development of the reproductive organs. Parasitology (in press).
79. Harayama H, Muroga M, Miyake M (2004) A cyclic adenosine 39,59-
monophosphate-induced tyrosine phosphorylation of Syk protein tyrosine kinase
in the flagella of boar spermatozoa. Mol Reprod Dev 69: 436–447.
80. Nollen PM (1997) Reproductive Physiology and Behaviour of Digenetic
Trematodes. In Advances in Trematode Biology (ed. Fried, B. and Graczyk, T. K.),
117–148. CRC Press, Boca Raton - New York.
81. Krautz-Peterson G, Radwanska M, Ndegwa D, Shoemaker CB, Skelly PJ (2007)
Optimizing gene suppression in schistosomes using RNA interference. Mol
Biochem Parasitol 153: 194–202.
82. Stricker SA, Smythe TL (2006) Differing mechanisms of cAMP- versus seawater-
induced oocyte maturation in marine nemertean worms II. The roles of tyrosine
kinases and phosphatases. Mol Reprod Dev 73: 1564–1577.
83. Grevelding CG (1995) The female-specific W1 sequence of the Puerto Rican
strain of Schistosoma mansoni occurs in both genders of a Liberian strain. Mol
Biochem Parasitol 71: 269–272.
84. Correnti JM, Brindley PJ, Pearce EJ (2005) Long-term suppression of cathepsin
B levels by RNA interference retards schistosome growth. Mol Biochem
Parasitol 143: 209–215.
85. Browaeys-Poly E, Cailliau K, Vilain JP (2000) Signal transduction pathways
triggered by fibroblast growth factor receptor 1 expressed in Xenopus laevis
oocytes after fibroblast growth factor 1 addition. Role of Grb2, phosphatidy-
linositol 3-kinase, Src tyrosine kinase, and phospholipase C gamma.
Eur J Biochem 267: 6256–6263.
SmTK4 of S. mansoni
PLoS Pathogens | www.plospathogens.org 17 February 2010 | Volume 6 | Issue 2 | e1000769